Accelerating Toward Curing Myeloma: Emerging Data, New Agents, and an Evolving Treatment Paradigm

In this online program a group of international myeloma experts discuss current treatment options for patient care across the spectrum of myeloma and highlight new approaches to optimize therapy. Read expert commentaries listen to a podcast FAQ discussion and download slides from a live Webinar on the most recent clinical data to learn more about how to manage your patients with myeloma.

Share

Program Content

Activities

Key Issues in Myeloma
Key Issues in Myeloma Treatment Today
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: November 23, 2020

Expires: November 22, 2021

FAQ in Myeloma
Experts Answer Frequently Asked Questions on Myeloma Management
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2021

Expires: January 26, 2022

Activities

Smoldering MM
Early Treatment for High-Risk Smoldering MM: Going for a Cure?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Frontline Treatment for Newly Diagnosed MM
Individualized Approaches to Frontline Treatment Selection for Newly Diagnosed MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Treating Relapsed/Refractory MM
How to Treat Relapsed/Refractory Multiple Myeloma in 2020
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

BCMA-Directed Therapy
BCMA-Directed Therapy For Patients with R/R MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Future Directions: MM
Future Directions, Key Studies from ASH 2020, and New 2021 Treatment Algorithm for MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

<i>EP</i>: Toward Curing MM
ExpressPoints: Accelerating Toward Curing Myeloma: Emerging Data, New Agents, and an Evolving Treatment Paradigm
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 30, 2020

Expires: December 29, 2021

Activities

MM Question & Answer
Expert Answers to Questions on Contemporary Management of Multiple Myeloma
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 22, 2021

Expires: April 21, 2022

Faculty

cover img faculity

Brian G. M. Durie, MD

National Director, Hematologic Malignancies and Multiple Myeloma
Aptium Oncology, Inc.
Co-Chair, Myeloma Committee – SWOG
Chairman, International Myeloma Foundation
Specialist, Multiple Myeloma and Related Disorders
Cedars-Sinai Outpatient Cancer Center
Los Angeles, California

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

cover img faculity

Philippe Moreau, MD

Professor of Clinical Hematology
University Hospital of Nantes
Nantes, France

cover img faculity

S. Vincent Rajkumar, MD

Professor of Medicine
Chair, Myeloma Amyloidosis Dysproteinemia Group
Mayo Clinic
Rochester, Minnesota

cover img faculity

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

cover img faculity

Jesús F. San-Miguel, MD, PhD

Head, Hematology Department
Professor of Medicine
Hospital Universitario de Salamanca and Centro de Investigación del Cáncer
University of Salamanca
Salamanca, Spain

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Bristol Myers Squibb

GlaxoSmithKline

Karyopharm

Oncopeptides

Partners

International Myeloma Foundation

ProCE Banner